Fig. 2From: The added value of positron emission tomography/computed tomography (PET/CT) in assessment of treatment response of secondary malignant osseous lesions: our experienceA 56-year-old male patient with history of NHL. a Conventional CT study showing no gross lytic or sclerotic lesions noted within the sternum and DV5 body. b, c Corresponding PET/CT fused image shows focal FDG uptake in the sternum and DV5 vertebral body matching with radiologically occult bone marrow infiltration, SUV Max of the vertebral lesion: 4.05 d 7 months post treatment PET/CT fused image showing complete metabolic response with disappearance of the metabolically active bone marrow lesions by the visual assessment methodBack to article page